(Q61711480)
Statements
Recombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes (English)
Jacek M Witkowski
Boleslaw Rutkowski
scientific article published on 01 March 2010